Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Scientific Reports
|
April 17, 2021
Highlighting the compound risk of COVID-19 and environmental pollutants using geospatial technology
Ram Kumar Singh, Martin Drews, Manuel De la Sen, et al.
Environment, Development and Sustainability
|
February 14, 2023
Nitrogen dioxide as proxy indicator of air pollution from fossil fuel burning in New Delhi during lockdown phases of COVID-19 pandemic period: impact on weather as revealed by Sentinel-5 precursor (5p) spectrometer sensor
Pavan Kumar, Aishwarya, Prashant Kumar Srivastava, et al.
Oncotarget
|
February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Vanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Cancer
|
June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
Vijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Scientific Reports
|
April 17, 2021
Highlighting the compound risk of COVID-19 and environmental pollutants using geospatial technology
Ram Kumar Singh, Martin Drews, Manuel De la Sen, et al.
Environment, Development and Sustainability
|
February 14, 2023
Nitrogen dioxide as proxy indicator of air pollution from fossil fuel burning in New Delhi during lockdown phases of COVID-19 pandemic period: impact on weather as revealed by Sentinel-5 precursor (5p) spectrometer sensor
Pavan Kumar, Aishwarya, Prashant Kumar Srivastava, et al.
Oncotarget
|
February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Vanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Cancer
|
June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
Vijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
Page
of 2